Pharma
Moderna's Post-COVID Reputation Reset
Moderna's post-COVID rebuild: revenue cliff, mRNA pipeline pivot, individualized cancer vaccine bet, and the brand-narrative challenge of staying credible without a vaccine windfall.
Tag
mRNA
Health Tech
Making Biotech Advances Known: A Communications Strategy
Biotech communications has to bridge scientific precision and public accessibility. How the category — CRISPR, mRNA, GLP-1, AI drug discovery — does it now.